Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
C. M. Raynaud, E. I. Ahmed, A. Jabeen, A. Sanchez, S. Sherif, T. C. Carneiro-Lobo, A. Awad, D. Awartani, A. Naik, R. Thomas, J. Decock, G. Zoppoli, D. Bedognetti, W. Hendrickx
This study shows that increasing SLFN11 expression through CRISPR-dCas9 systems enhances DNA damage response sensitivity in breast cancer cells.
bioRxiv · Apr 2, 2023 · PreprintCancer Biology
D. Rinchai, S. Deola, G. Zoppoli, B. S. A. Kabeer, S. A. Taleb, I. Pavlovski, S. Maacha, G. Gentilcore, M. Toufiq, L. Matthew, L. Liu, F. R. Vempalli, G. Mubarak, S. Lorenz, I. Sivieri, , D. Chaussabel
This study uses high-temporal-resolution transcriptome profiling to compare interferon responses after mRNA vaccination and SARS-CoV-2 infection, identifying distinct signatures linked to immune outcomes.
bioRxiv · Dec 12, 2021 · PreprintImmunology
C. Winkler, D. Ferraioli, A. Garuti, F. Grillo, J. Rodriguez-Canales, L. Ferrando, N. Chopin, I. Ray-Coquard, D. Bedognetti, A. Ballestrero, E. Leo, G. Zoppoli
The paper quantifies SLFN11 in ovarian cancer tissues and shows its expression in immune cells, linking it to favorable outcomes and cancer-immunity interactions related to platinum sensitivity.
bioRxiv · May 22, 2020Cancer Biology
D. Rinchai, B. Kabeer, M. Toufiq, Z. Calderone, S. Deola, T. Brummaier, M. Garand, R. Branco, N. Baldwin, M. Alfaki, M. Altman, A. Ballestrero, M. Bassetti, G. Zoppoli, A. De Maria, , D. Chaussabel
The paper develops a modular framework for designing targeted blood transcript profiling panels to study the immune response to SARS-CoV-2 infection.
bioRxiv · May 20, 2020Immunology
J. Roelands, W. Hendrickx, P. J. K. Kuppen, R. Mall, G. Zoppoli, M. Saad, K. Halliwill, G. Curigliano, D. Rinchai, J. Decock, L. Delogu, T. Turan, J. Samayoa, L. Chouchane, E. Wang, , D. Bedognetti
The paper analyzes tumor-host interactions across 31 cancer types using the ICR signature to identify prognostic and predictive implications of immune phenotypes.
bioRxiv · May 8, 2019Cancer Biology